RecruitingNCT03146884
Swiss Autoimmune Hepatitis Cohort Study
Sponsor
Fondazione Epatocentro Ticino
Enrollment
500 participants
Start Date
Feb 16, 2017
Study Type
OBSERVATIONAL
Conditions
Summary
Research project in which biological material is sampled and health-related personal data is further used and collected. Coded data are used.
Eligibility
Inclusion Criteria2
- diagnosis of AIH, either type I or type II
- Only patients living in Switzerland
Exclusion Criteria1
- N/A
Interested in this trial?
Get notified about updates and connect with the research team.
Locations(20)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT03146884
Related Trials
Liver-gut Axis Study Through Identification of Liver Disease-specific Microbiome
NCT065191621 location
Belimumab in Autoimmune Hepatitis
NCT063814535 locations
A Study of SIPLIZUMAB in AILD and LT Patients
NCT064552801 location
Conception of a Diagnosis, Prognosis and Therapeutic Decision Tool for Patients With Autoimmunity and Inflammation
NCT049028071 location
A-LiNK: Improving Outcomes in Autoimmune Liver Disease
NCT057504988 locations